Document Detail


Longitudinal Analysis of Maternal Plasma Apolipoproteins in Pregnancy: A Targeted Proteomics Approach.
MedLine Citation:
PMID:  23059768     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Minimally invasive diagnostic tests are needed in obstetrics to identify women at risk for complications during delivery. The apolipoproteins fluctuate in complexity and abundance in maternal plasma during pregnancy and could be incorporated into a blood test to evaluate this risk. The objective of this study was to examine the relative plasma concentrations of apolipoproteins and their biochemically modified subtypes (i.e., proteolytically processed, sialyated, cysteinylated, dimerized) over gestational time using a targeted mass spectrometry approach. Relative abundance of modified and unmodified apolipoproteins AI, AII, CI, CII, and CIII was determined by surface-enhanced laser desorption ionization mass spectrometry (SELDI-TOF MS) in plasma prospectively collected from 11 gravidas with uncomplicated pregnancies at 4-5 gestational time points per patient. Apolipoproteins were readily identifiable by spectral pattern. Apo C-III(2) and Apo C-III(1) (doubly and singly sialylated Apo C-III subtypes) increased with gestational age (r(2)>0.8). Unmodified Apo A-II, Apo C-I, and Apo C-III(0) showed no correlation (r(2)=0.01-0.1). Pro Apo C-II did not increase significantly until third trimester (140 ± 13% of first trimester), but proteolytically cleaved, mature Apo C-II increased in late pregnancy (702 ± 130% of first trimester). Mature Apo C-II represented 6.7 ± 0.9% of total Apo C-II in early gestation and increased to 33 ± 4.5% in third trimester. A label free, semi-quantitative targeted proteomics approach was developed using LTQ-Orbitrap mass spectrometry to confirm the relative quantitative differences in Apo C-III and Apo C-II subtypes between first and third trimesters observed by SELDI-TOF MS. Targeted apolipoprotein screening was applied to a cohort of term and preterm patients. Modified Apo A-II isoforms were significantly elevated in plasma from mothers who delivered prematurely relative to term controls (p=0.02). These results support a role for targeted proteomics profiling approaches to monitor healthy pregnancies and assess risk of adverse obstetric outcomes.
Authors:
Shannon K Flood-Nichols; Deborah Tinnemore; Mark A Wingerd; Ali I Abu-Alya; Peter G Napolitano; Jonathan D Stallings; Danielle L Ippolito
Related Documents :
22861158 - Surgical treatment of ectopic pregnancy associated with predisposing factors of tuboper...
12533398 - Estrogen synthesis in fetal sheep brain: effect of maternal treatment with an aromatase...
17955188 - Effect of hormonal status and metabolic changes of restricted ewes during late pregnanc...
3047418 - Radio ultrasound observations of the fetotoxic effects in sheep from ingestion of coniu...
10459458 - Herpes simplex genitalis type 2: our experiences.
17434508 - Reassessing the value of varicocelectomy as a treatment for male subfertility with a ne...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-10-10
Journal Detail:
Title:  Molecular & cellular proteomics : MCP     Volume:  -     ISSN:  1535-9484     ISO Abbreviation:  Mol. Cell Proteomics     Publication Date:  2012 Oct 
Date Detail:
Created Date:  2012-10-12     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101125647     Medline TA:  Mol Cell Proteomics     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Madigan Healthcare System, United States.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Facile synthesis of the pentasaccharide repeating unit of the cell wall O-antigen of Escherichia col...
Next Document:  Cardiopulmonary Variables During Exercise Predict Pregnancy Outcome in Women With Congenital Heart D...